Generate Biomedicines

Generate gains another $1B-plus Big Pharma partner in Novartis

Novartis has inked a deal potentially worth more than $1 billion with Flagship's Generate to develop protein therapeutics across multiple indications.

Gabrielle Masson Sep 24, 2024 6:00am

BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders

May 3, 2024 8:30am

AI robot drug discovery test tube machine learning

AI can make plenty of molecules, Generate can't do it alone

Jan 4, 2024 6:00am

graphic of a bull and a bear wrapped up in financial trading information

Generate raises huge $273M series C, a little short of 2021 haul

Sep 14, 2023 6:00am

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am

Amgen vet to be CMO at Affini-T—Chutes & Ladders

Jul 29, 2022 9:30am